| Literature DB >> 2375641 |
N G Schwob1, J Nalbantoglu, K E Hastings, T Mikkelsen, N R Cashman.
Abstract
We developed a novel quantitative assay to test the hypothesis that defects in DNA cytosine methylation might be responsible for the brain chromatin abnormalities and transcriptional alterations observed in patients with Alzheimer's disease (AD). We found no significant difference in percent methylation of CCGG sites from brain DNA of 44 patients with AD compared with 20 normal subjects. These results, however, would not exclude genomic redistribution of methylcytosine in AD, or disturbed methylation of a limited population of critical brain-specific genes.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2375641 DOI： 10.1002/ana.410280117
Source DB: PubMed Journal: Ann Neurol ISSN： 0364-5134 Impact factor: 10.422